Sees Q4 revenue $810M-$840M, consensus $878.78M. The midpoint of this guidance range represents an 8% year-on-year increase, excluding the impact of divestitures. The Company also expects adjusted EBITDA of approximately 28.5% to 29.5% of sales.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks